RobertDLegareMD

Oncology • Westerly, RI

Associate Professor of Medicine, Brown University

Join to view full profile

Dr. Legare is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Legare's full profile

Already have an account?

Office
Smilow Cancer Hospital
25 Wells Street
Westerly, RI 02891
Phone+1 401-656-4950

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1992 - 1996
Yale-New Haven Medical CenterResidency, Internal Medicine, 1990 - 1992
Tufts University School of MedicineClass of 1990

Certifications & Licensure

MA State Medical License 1992 - 2026
RI State Medical License 1997 - 2026
CT State Medical License 1996 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2010-2014
America's Top Doctors for Cancer Castle Connolly, 2009-2013
Top MD Consumers Checkbook

Publications & Presentations

PubMed

Immunohistochemical findings and clinicopathological features of breast cancers with pathogenic germline mutations in Non-BRCA genes.
Kamaljeet Singh, Jennifer Scalia, Robert Legare, M Ruhul Quddus, C James Sung
Human Pathology. 2024-04-01
2 citations
Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.
Mary L Lopresti, Jessica J Bian, Bachir J. Sakr, Rochelle Strenger, Robert D. Legare
Breast Cancer Research and Treatment. 2021-06-04
85 citations
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFOR...
Nadine Tung, Banu Arun, Michele R. Hacker, E Hofstatter, Deborah Toppmeyer
Journal of Clinical Oncology. 2020-02-25

Press Mentions

Five Questions with: Dr. Joseph Renzulli, Dr. Sanjay Aneja and Dr. Matthew AustinDecember 18th, 2022
Lawrence + Memorial Hospital Using Precision Medicine to Treat Breast CancerOctober 14th, 2021
Smilow Cancer Hospital Care Center at Waterford Physician Makes ‘Top Docs’ List in ConnecticutJune 23rd, 2021
Join now to see all